Table 4

Previous studies regarding heart failure following MI

ArticleYear(s) of index MIMI type (STEMI/NSTEMI)n=PCIThrombolysisFUHF incidenceHF definition
Desta et al 3 Overall1996–2008Both199 851N/AN/ADuring hospitalisation for index MI28%–46%Presence of crackles (Killip class ≥II) or use of intravenous diuretic agents or intravenous inotropes.
Most recent reported period2008STEMI15 62591.5%8.5%28%
Kaul et al 4 2002 to 2008STEMI940659.4% without index HF
46.7% with index HF
N/A1 year23.4%Index HF: HF as a complication during index ACS hospitalisation.
Postdischarge HF: HF after discharge from index ACS hospitalisation.
NSTEMI11 008N/AN/A1 year25.4%
Velagaleti et al 11 1990 to 1999Both195N/AN/A5 years31.9%Framingham criteria for HF (2 major or 1 major and 2 minor criteria)
Torabi et al 13 1998Both8962.2% (n=20)41.5% (n=372)7 years (retrospective)41% at index admission
35% after discharge
Signs and symptoms consistent with HF diagnosis and treatment with loop diuretics.
Najafi et al 14 1984 to 1993Both31093.2%32.4%Median FU 14.4 years13.1%Admission to hospital with HF diagnosis >28 days after index MI.
Hellerman et al 15 1979 to 1994Both1537N/AN/AMean FU 7.6 years36%Framingham criteria for HF (2 major or 1 major and 2 minor criteria)
Ezekowitz et al 12 1994 to 2000Both773311.8%N/A5 years76%Concurrent HF: HF developing as a complication of the index
Subsequent HF: a hospitalisation or physician claim for HF occurring after the index MI.
Gjesing et al 17 Overall1997 to 2010Both89 3892.5%–38.2%N/A90 days19.6%–23.6%HF diagnosis or incident use of loop diuretics
Most recent reported period2009 to 2010Both10.52038.2%N/A90 days19.6%
Taniguchi et al 10 2005 to 2007STEMI3682100%N/AMedian 1956 days4.4 %/year in first year
1.0 %/year beyond 1 year to 5 years
Hospitalisation due to worsening HF requiring intravenous drug therapy
Sulo et al 16 2001 to 2009Both69 37238.6%N/A1 year17.1% at index admission
5.4% after discharge
Discharge diagnosis codes (ICD-10 codes, 150.x)
  • *Both=STEMI and NSTEMI.

  • ACS, acute coronary syndrome; FU, follow-up; HF, heart failure; MI, myocardial infarction; NSTEMI, non-ST-elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST-elevation myocardial infarction.